Z. Landau et al., PRESENCE OF INFECTIVE EPSTEIN-BARR-VIRUS IN THE URINE OF PATIENTS WITH INFECTIOUS-MONONUCLEOSIS, Journal of medical virology, 44(3), 1994, pp. 229-233
The presence of Epstein-Barr virus (EBV) in the blood and urine of 20
patients with infectious mononucleosis (IM) was investigated together
with the clinical course of the disease, and in 9 patients up to 2-7 m
onths after recovery. EBV DNA, analyzed by the polymerase chain reacti
on (PCR), was detected in the blood of all 20 patients from the first
sample obtained and detected between 3 to 42 days from the beginning o
f symptoms and up to 2-3 months after recovery. In the urine, EBV DNA
was detected in 15 out of 16 (93%) patients in the first sample obtain
ed and detected between 3 to 50 days during the clinical course of the
disease. In four patients EBV DNA was detected in the urine up to 3 m
onths after full recovery. Seventeen out of 26 (65%) urine samples inc
luding 3 which were obtained 2-7 months after recovery infected B cell
s as assessed by PCR. Nine out of 12 (75%) urine samples tested induce
d Epstein-Barr nuclear antigen (EBNA) in the infected B-cell line. In
addition to the persistence of EBV in the blood of IM patients, these
studies show for the first time the presence of infective EBV in the u
rine during the clinical course of the disease and up to 7 months afte
r full clinical recovery. (C) 1994 Wiley-Liss, Inc.